Class I Phosphatidylinositol 3-Kinases, antagonists & inhibitors

All categories
Name
Class I Phosphatidylinositol 3-Kinases, antagonists & inhibitors
Accession Number
DBCAT002856
Description

Not Available

Drugs
DrugDrug Description
CH-5132799CH5132799 has been used in trials studying the treatment of Solid Tumors.
AlpelisibAlpelisib is indicated in combination with fulvestrant to treat postmenopausal women, and men, with advanced or metastatic breast cancer. This cancer must be hormone receptor (HR)-positive, human epidermal growth factor...
Drugs & Drug Targets
DrugTargetType
AlpelisibPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformtarget
AlpelisibCytochrome P450 3A4enzyme
AlpelisibCytochrome P450 2C9enzyme
AlpelisibCytochrome P450 2C8enzyme
AlpelisibCytochrome P450 2C19enzyme
AlpelisibATP-binding cassette sub-family G member 2transporter
AlpelisibP-glycoprotein 1transporter